Diana Carmona, MD
Gynecologic Oncology · Weirton, WVNPI 1841262656
Payments from drug & device makers
Across 52 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$190
- Sage Therapeutics, LLC$125
- Bayer$112
- Amgen$65
- AbbVie$63
- Mayne Pharma Commercial LLC$58
- plus $303 from 14 others
What the payments were for
- Food & beverage$88396%
- Education$334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 11 | $190 |
| Sage Therapeutics, LLC | 6 | $125 |
| Bayer | 4 | $112 |
| Amgen | 4 | $65 |
| AbbVie | 3 | $63 |
| Mayne Pharma Commercial LLC | 5 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Millicent US Inc | 2 | $34 |
| Merck | 2 | $33 |
| Astellas Pharma US Inc | 2 | $31 |
| Novo Nordisk | 2 | $28 |
| Axonics, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Pfizer | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Octapharma USA, Inc. | 1 | $14 |
| Exeltis, USA Inc. | 1 | $14 |
| Minerva Surgical, Inc | 1 | $12 |
| Alydia Health | 1 | $10 |
| Meditrina | 1 | $9 |
How this compares
Too few gynecologic oncology providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 43 | $3,272 |
| Ibandronate Sodium | 20 | $515 |
| Nystatin | 16 | $176 |
| Fluconazole | 14 | $95 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Weirton
- Nadim Bou ZgheibHuntington$593K
- William McBeeMorgantown$35K
- Kristy WardMorgantown$33K
- Stephen BushCharleston$30K
- Michael SchianoCharleston$4K
- Mohammed AshrafMorgantown$29
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.